Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil].
Vieira Neto L, Abucham J, Araujo LA, Boguszewski CL, Bronstein MD, Czepielewski M, Jallad RS, Musolino NR, Naves LA, Ribeiro-Oliveira Júnior A, Vilar L, Faria Mdos S, Gadelha MR. Vieira Neto L, et al. Among authors: faria mdos s. Arq Bras Endocrinol Metabol. 2011 Mar;55(2):91-105. doi: 10.1590/S0004-27302011000200001. Arq Bras Endocrinol Metabol. 2011. PMID: 21584426 Review. Portuguese.
[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil].
Vieira Neto L, Abucham J, Araujo LA, Boguszewski CL, Bronstein MD, Czepielewski M, Jallad RS, Musolino NR, Naves LA, Ribeiro-Oliveira Júnior A, Vilar L, Faria Mdos S, Gadelha MR. Vieira Neto L, et al. Among authors: faria mdos s. Arq Bras Endocrinol Metabol. 2011 Dec;55(9):725-6. doi: 10.1590/s0004-27302011000900011. Arq Bras Endocrinol Metabol. 2011. PMID: 22231978 Portuguese. No abstract available.
Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.
Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Sheppard M; Pasireotide C2305 Study Group. Colao A, et al. J Clin Endocrinol Metab. 2014 Mar;99(3):791-9. doi: 10.1210/jc.2013-2480. Epub 2014 Jan 13. J Clin Endocrinol Metab. 2014. PMID: 24423324 Free PMC article. Clinical Trial.
Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients.
Vilar L, Freitas MC, Naves LA, Casulari LA, Azevedo M, Montenegro R Jr, Barros AI, Faria M, Nascimento GC, Lima JG, Nóbrega LH, Cruz TP, Mota A, Ramos A, Violante A, Lamounier Filho A, Gadelha MR, Czepielewski MA, Glezer A, Bronstein MD. Vilar L, et al. J Endocrinol Invest. 2008 May;31(5):436-44. doi: 10.1007/BF03346388. J Endocrinol Invest. 2008. PMID: 18560262
Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
Czepielewski MA, Garret Q, Vencio SAC, Rassi N, Felicio JS, Faria MS, Senn CCP, Bronstein MD, Cerqueira MJAG, Neves ACL, Sgarbi JA, Spinola-Castro AM, Cunha MPR, Bandeira F, Toffoletto O, Afiune J, Baradelli R, Rodrigues DG, Scharf M. Czepielewski MA, et al. Growth Horm IGF Res. 2019 Oct-Dec;48-49:29-35. doi: 10.1016/j.ghir.2019.07.003. Epub 2019 Aug 2. Growth Horm IGF Res. 2019. PMID: 31493626 Clinical Trial.
Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.
Czepielewski MA, Garret Q, Vencio SAC, Rassi N, Faria MS, Senn CCP, Bronstein MD, Cerqueira MJAG, Neves ACL, Spinola-Castro AM, Cunha MPR, Leite NR, Wassermann GE, Alegria MC, Toffoletto O, Afiune J, Baradelli R, Rodrigues DG, Scharf M. Czepielewski MA, et al. Growth Horm IGF Res. 2021 Feb;56:101372. doi: 10.1016/j.ghir.2020.101372. Epub 2020 Nov 28. Growth Horm IGF Res. 2021. PMID: 33260063 Clinical Trial.
Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league.
Ribeiro MJ, Figueiredo Neto JA, Memória EV, Lopes Mde C, Faria Mdos S, Salgado Filho N, Oliveira TC. Ribeiro MJ, et al. Among authors: faria mdos s. Arq Bras Cardiol. 2009 Jan;92(1):39-45. doi: 10.1590/s0066-782x2009000100007. Arq Bras Cardiol. 2009. PMID: 19219263 Free article. English, Portuguese, Spanish.